50 results
Page 2 of 3
6-K
gh03up1aevv8kl3cn
24 Jul 24
Current report (foreign)
4:35pm
6-K
EX-99.4
gk4m7oa
24 Jul 24
Current report (foreign)
4:35pm
6-K
EX-99.1
lmwmr91
5 Jul 24
Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
6:03am
F-1/A
r03gnxyhrbglceyrh44
6 May 24
Registration statement (foreign) (amended)
8:27pm
F-1/A
fqdwt
18 Apr 24
Registration statement (foreign) (amended)
6:03am
6-K
EX-99.1
e24in 2csnl
15 Mar 24
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
5:10pm
6-K
EX-99.1
19sui558v2x1w8 sy4
12 Mar 24
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
5:25pm
6-K
EX-99.2
ikpi33 1igo98taqx
12 Mar 24
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
5:25pm
6-K
EX-99.3
pb4qims
12 Mar 24
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
5:25pm
F-1
mqt5 ekpjrf
9 Feb 24
Registration statement (foreign)
4:09pm
20-F
EX-4.8
87wv29p2 0jo82kj
31 Jan 24
Annual report (foreign)
5:05pm
20-F
EX-4.9
apkh sw5f9hf
31 Jan 24
Annual report (foreign)
5:05pm
20-F
EX-4.15
f80dyveagmr 3m
31 Jan 24
Annual report (foreign)
5:05pm
20-F
EX-4.16
oofd efh4m
31 Jan 24
Annual report (foreign)
5:05pm
20-F
x1ghywh
31 Jan 24
Annual report (foreign)
5:05pm
20-F
EX-4.4
cd5fs3legd8k yzpj8m
31 Jan 24
Annual report (foreign)
5:05pm
425
EX-10.1
ugcqw1 xwow9376
17 Jan 24
Business combination disclosure
6:00am
425
EX-99.1
entys5hid zjasoho
17 Jan 24
Business combination disclosure
6:00am
425
wxxhigyt
15 Nov 23
Business combination disclosure
5:15pm